AI-assisted, human-published
12/01/2025 /Funding Events
Protego Biopharma Secures $130M Series B Funding for Protein Misfolding Disorders Treatment
San Diego-based Protego Biopharma concludes $130 million Series B financing round to advance PROT-001 into pivotal clinical trials for AL amyloidosis, targeting the root cause of the disease.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com